Last 12 months
Inside the activity.
0 purchase rows · 19 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 8 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 08, 2021 Filed Apr 12, 2021 22:24 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 5,914 | $203.22 | $1,201,819.42 |
DisclosureSEC source: 0001073397-21-000002 · edgardoc.xml · nonDerivative · entry 1 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 955,929 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.69 to $203.63, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| April 05, 2021 Filed Apr 5, 2021 21:49 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 25 | $208.50 | $5,212.50 |
DisclosureSEC source: 0001073397-21-000001 · edgardoc.xml · nonDerivative · entry 11 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 961,843 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2021. F2 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| April 05, 2021 Filed Apr 5, 2021 21:49 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 244 | $207.45 | $50,617.31 |
DisclosureSEC source: 0001073397-21-000001 · edgardoc.xml · nonDerivative · entry 10 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 961,868 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2021. F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $207.42 to $207.53, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| April 05, 2021 Filed Apr 5, 2021 21:49 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 448 | $205.61 | $92,114.89 |
DisclosureSEC source: 0001073397-21-000001 · edgardoc.xml · nonDerivative · entry 9 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 962,112 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2021. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $205.58 to $205.81, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| April 05, 2021 Filed Apr 5, 2021 21:49 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 6,365 | $205.01 | $1,304,886.10 |
DisclosureSEC source: 0001073397-21-000001 · edgardoc.xml · nonDerivative · entry 8 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 962,560 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2021. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $204.52 to $205.50, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| April 05, 2021 Filed Apr 5, 2021 21:49 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 3,118 | $204.11 | $636,404.38 |
DisclosureSEC source: 0001073397-21-000001 · edgardoc.xml · nonDerivative · entry 7 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 968,925 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2021. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $203.51 to $204.45, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 21:49 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 800 | $209.62 | $167,699.76 |
DisclosureSEC source: 0001073397-21-000001 · edgardoc.xml · nonDerivative · entry 6 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 972,043 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2021. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $209.57 to $209.75, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 21:49 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 5,745 | $208.93 | $1,200,302.28 |
DisclosureSEC source: 0001073397-21-000001 · edgardoc.xml · nonDerivative · entry 5 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 972,843 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2021. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $208.55 to $209.53, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 21:49 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 2,389 | $207.90 | $496,675.73 |
DisclosureSEC source: 0001073397-21-000001 · edgardoc.xml · nonDerivative · entry 4 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 978,588 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2021. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $207.53 to $208.52, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 21:49 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 4,119 | $207.13 | $853,157.76 |
DisclosureSEC source: 0001073397-21-000001 · edgardoc.xml · nonDerivative · entry 3 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 980,977 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2021. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $206.52 to $207.50, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 21:49 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 1,347 | $206.10 | $277,615.08 |
DisclosureSEC source: 0001073397-21-000001 · edgardoc.xml · nonDerivative · entry 2 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 985,096 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2021. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $205.48 to $206.47, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 21:49 UTC |
LOPEZ GEORGE ADirector · 10% owner
|
SaleCommon Stock | 400 | $203.00 | $81,200.00 |
DisclosureSEC source: 0001073397-21-000001 · edgardoc.xml · nonDerivative · entry 1 LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 986,443 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2021. F2 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| March 31, 2021 Filed Mar 31, 2021 21:45 UTC |
SWINNEY ROBERT SDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,500 | $0.00 Strike: $44.82 | $0.00 |
DisclosureSEC source: 0001073398-21-000003 · edgardoc.xml · derivative · entry 3 SWINNEY ROBERT S · CIK 0001073398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2021-04-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 31, 2021 Filed Mar 31, 2021 21:45 UTC |
SWINNEY ROBERT SDirector
|
Exercise / conversionCommon Stock | 1,500 | $44.82 | $67,230.00 |
DisclosureSEC source: 0001073398-21-000003 · edgardoc.xml · nonDerivative · entry 1 SWINNEY ROBERT S · CIK 0001073398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,005 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 02:22 UTC |
Bonnell Brian MichaelChief Financial Officer
|
GrantCommon Stock · Derivative | 6,628 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001804831-21-000001 · edgardoc.xml · derivative · entry 7 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,628 Underlying: Common Stock · 6,628 shares Expires 2024-03-08 F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 02:18 UTC |
Jain VivekDirector · Chairman and CEO
|
GrantCommon Stock · Derivative | 7,574 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001410442-21-000006 · edgardoc.xml · derivative · entry 9 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,574 Underlying: Common Stock · 7,574 shares Expires 2024-03-08 F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 02:13 UTC |
Voigtlander Christian B.Chief Operating Officer
|
GrantCommon Stock · Derivative | 6,628 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001727477-21-000002 · edgardoc.xml · derivative · entry 8 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,628 Underlying: Common Stock · 6,628 shares Expires 2024-03-08 F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 02:08 UTC |
McGrody Kevin JChief Accounting Officer
|
GrantCommon Stock · Derivative | 2,525 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001615192-21-000001 · edgardoc.xml · derivative · entry 7 McGrody Kevin J · CIK 0001615192 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,525 Underlying: Common Stock · 2,525 shares Expires 2024-03-08 F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:22 UTC |
Bonnell Brian MichaelChief Financial Officer
|
Exercise / conversionCommon Stock · Derivative | 1,550 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001804831-21-000001 · edgardoc.xml · derivative · entry 6 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,102 Underlying: Common Stock · 1,550 shares Expires 2023-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F4 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:22 UTC |
Bonnell Brian MichaelChief Financial Officer
|
Exercise / conversionCommon Stock · Derivative | 722 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001804831-21-000001 · edgardoc.xml · derivative · entry 5 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 722 Underlying: Common Stock · 722 shares Expires 2022-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F4 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:22 UTC |
Bonnell Brian MichaelChief Financial Officer
|
Tax withholdingCommon Stock | 816 | $0.00 | $0.00 |
DisclosureSEC source: 0001804831-21-000001 · edgardoc.xml · nonDerivative · entry 4 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,782 Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:22 UTC |
Bonnell Brian MichaelChief Financial Officer
|
Exercise / conversionCommon Stock | 1,550 | $0.00 | $0.00 |
DisclosureSEC source: 0001804831-21-000001 · edgardoc.xml · nonDerivative · entry 3 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,598 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:22 UTC |
Bonnell Brian MichaelChief Financial Officer
|
Tax withholdingCommon Stock | 380 | $0.00 | $0.00 |
DisclosureSEC source: 0001804831-21-000001 · edgardoc.xml · nonDerivative · entry 2 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,048 Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:22 UTC |
Bonnell Brian MichaelChief Financial Officer
|
Exercise / conversionCommon Stock | 722 | $0.00 | $0.00 |
DisclosureSEC source: 0001804831-21-000001 · edgardoc.xml · nonDerivative · entry 1 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,428 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:18 UTC |
Jain VivekDirector · Chairman and CEO
|
Exercise / conversionCommon Stock · Derivative | 1,444 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-21-000006 · edgardoc.xml · derivative · entry 11 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,444 Underlying: Common Stock · 1,444 shares Expires 2022-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:18 UTC |
Jain VivekDirector · Chairman and CEO
|
Exercise / conversionCommon Stock · Derivative | 2,681 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-21-000006 · edgardoc.xml · derivative · entry 10 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,681 shares Expires 2021-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:18 UTC |
Jain VivekDirector · Chairman and CEO
|
Exercise / conversionCommon Stock · Derivative | 1,772 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001410442-21-000006 · edgardoc.xml · derivative · entry 8 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,545 Underlying: Common Stock · 1,772 shares Expires 2023-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:18 UTC |
Jain VivekDirector · Chairman and CEO
|
Tax withholdingCommon Stock | 932 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-21-000006 · edgardoc.xml · nonDerivative · entry 6 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,844 Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:18 UTC |
Jain VivekDirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 1,772 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-21-000006 · edgardoc.xml · nonDerivative · entry 5 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,776 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:18 UTC |
Jain VivekDirector · Chairman and CEO
|
Tax withholdingCommon Stock | 760 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-21-000006 · edgardoc.xml · nonDerivative · entry 4 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,004 Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:18 UTC |
Jain VivekDirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 1,444 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-21-000006 · edgardoc.xml · nonDerivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,764 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:18 UTC |
Jain VivekDirector · Chairman and CEO
|
Tax withholdingCommon Stock | 1,411 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-21-000006 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,320 Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:18 UTC |
Jain VivekDirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 2,681 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-21-000006 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,731 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:13 UTC |
Voigtlander Christian B.Chief Operating Officer
|
Exercise / conversionCommon Stock · Derivative | 1,444 | $0.00 | $0.00 |
DisclosureSEC source: 0001727477-21-000002 · edgardoc.xml · derivative · entry 10 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,444 Underlying: Common Stock · 1,444 shares Expires 2022-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F3 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:13 UTC |
Voigtlander Christian B.Chief Operating Officer
|
Exercise / conversionCommon Stock · Derivative | 1,174 | $0.00 | $0.00 |
DisclosureSEC source: 0001727477-21-000002 · edgardoc.xml · derivative · entry 9 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,174 shares Expires 2021-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F3 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:13 UTC |
Voigtlander Christian B.Chief Operating Officer
|
Exercise / conversionCommon Stock · Derivative | 1,550 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001727477-21-000002 · edgardoc.xml · derivative · entry 7 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,102 Underlying: Common Stock · 1,550 shares Expires 2023-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F2 · derivative.exercise_date: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:13 UTC |
Voigtlander Christian B.Chief Operating Officer
|
Tax withholdingCommon Stock | 816 | $0.00 | $0.00 |
DisclosureSEC source: 0001727477-21-000002 · edgardoc.xml · nonDerivative · entry 6 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,050 Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:13 UTC |
Voigtlander Christian B.Chief Operating Officer
|
Exercise / conversionCommon Stock | 1,550 | $0.00 | $0.00 |
DisclosureSEC source: 0001727477-21-000002 · edgardoc.xml · nonDerivative · entry 5 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,866 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:13 UTC |
Voigtlander Christian B.Chief Operating Officer
|
Tax withholdingCommon Stock | 760 | $0.00 | $0.00 |
DisclosureSEC source: 0001727477-21-000002 · edgardoc.xml · nonDerivative · entry 4 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,316 Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:13 UTC |
Voigtlander Christian B.Chief Operating Officer
|
Exercise / conversionCommon Stock | 1,444 | $0.00 | $0.00 |
DisclosureSEC source: 0001727477-21-000002 · edgardoc.xml · nonDerivative · entry 3 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,076 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:13 UTC |
Voigtlander Christian B.Chief Operating Officer
|
Tax withholdingCommon Stock | 618 | $0.00 | $0.00 |
DisclosureSEC source: 0001727477-21-000002 · edgardoc.xml · nonDerivative · entry 2 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,632 Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:13 UTC |
Voigtlander Christian B.Chief Operating Officer
|
Exercise / conversionCommon Stock | 1,174 | $0.00 | $0.00 |
DisclosureSEC source: 0001727477-21-000002 · edgardoc.xml · nonDerivative · entry 1 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:02 UTC |
Woolson DanielVP, GM-Infusion Capital
|
Exercise / conversionPerformance Shares · Derivative | 1,418 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-21-000003 · edgardoc.xml · derivative · entry 6 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,835 Underlying: Common Stock · 1,418 shares Expires 2023-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F4 · derivative.exercise_date: These PRSUs were granted on March 6, 2020. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 6 of the first, second, and third year following the year of grant. Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:02 UTC |
Woolson DanielVP, GM-Infusion Capital
|
Exercise / conversionCommon Stock · Derivative | 1,444 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-21-000003 · edgardoc.xml · derivative · entry 5 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,444 Underlying: Common Stock · 1,444 shares Expires 2022-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F3 · derivative.exercise_date: These PRSUs were granted on March 6, 2019. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 6 of the first, second, and third year following the year of grant. Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:02 UTC |
Woolson DanielVP, GM-Infusion Capital
|
Tax withholdingCommon Stock | 628 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-21-000003 · edgardoc.xml · nonDerivative · entry 4 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,162 Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:02 UTC |
Woolson DanielVP, GM-Infusion Capital
|
Exercise / conversionCommon Stock | 1,418 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-21-000003 · edgardoc.xml · nonDerivative · entry 3 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,790 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU). Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:02 UTC |
Woolson DanielVP, GM-Infusion Capital
|
Tax withholdingCommon Stock | 639 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-21-000003 · edgardoc.xml · nonDerivative · entry 2 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,372 Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:02 UTC |
Woolson DanielVP, GM-Infusion Capital
|
Exercise / conversionCommon Stock | 1,444 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-21-000003 · edgardoc.xml · nonDerivative · entry 1 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,011 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU). Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:08 UTC |
McGrody Kevin JChief Accounting Officer
|
Exercise / conversionCommon Stock · Derivative | 886 | $0.00 | $0.00 |
DisclosureSEC source: 0001615192-21-000001 · edgardoc.xml · derivative · entry 10 McGrody Kevin J · CIK 0001615192 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,773 Underlying: Common Stock · 886 shares Expires 2023-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| March 06, 2021 Filed Mar 10, 2021 02:08 UTC |
McGrody Kevin JChief Accounting Officer
|
Exercise / conversionCommon Stock · Derivative | 1,011 | $0.00 | $0.00 |
DisclosureSEC source: 0001615192-21-000001 · edgardoc.xml · derivative · entry 9 McGrody Kevin J · CIK 0001615192 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,011 Underlying: Common Stock · 1,011 shares Expires 2022-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.